JSAM
J. Safra Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-308,731
| Closed | -$25M | – | 356 |
|
|
2025
Q1 | $25M | Buy |
308,731
+16,229
| +6% | +$1.32M | 2.09% | 15 |
|
|
2024
Q4 | $26.3M | Buy |
292,502
+240,415
| +462% | +$21.6M | 2.14% | 14 |
|
|
2024
Q3 | $5.13M | Buy |
52,087
+48,513
| +1,357% | +$4.78M | 0.49% | 22 |
|
|
2024
Q2 | $331K | Hold |
3,574
| – | – | 0.03% | 46 |
|
|
2024
Q1 | $339K | Hold |
3,574
| – | – | 0.04% | 32 |
|
|
2023
Q4 | $319K | Hold |
3,574
| – | – | 0.04% | 28 |
|
|
2023
Q3 | $261K | Hold |
3,574
| – | – | 0.04% | 31 |
|
|
2023
Q2 | $297K | Hold |
3,574
| – | – | 0.04% | 32 |
|
|
2023
Q1 | $272K | Sell |
3,574
-373,854
| -99% | -$28.5M | 0.04% | 28 |
|
|
2022
Q4 | $31.3M | Buy |
377,428
+341,878
| +962% | +$28.4M | 5.51% | 8 |
|
|
2022
Q3 | $448K | Buy |
35,550
+2,482
| +8% | +$31.3K | 7.44% | 5 |
|
|
2022
Q2 | $445K | Buy |
+33,068
| New | +$445K | 7.6% | 5 |
|